Forthcoming call: Advancing regenerative medicines and cell therapies
Date: March 14, 2014
The Technology Strategy Board and the Welsh Government are to invest up to £8m in single-company and collaborative R&D projects to support the UK’s burgeoning regenerative medicine and cell therapy industry.
The aim is to help advance the industry by addressing sector-specific challenges related to preparing novel treatments for use.
This competition will focus on the preclinical testing, clinical development and manufacture of regenerative medicines and cell therapies, and the development of associated underpinning tools and technologies.Back to News Overview